Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Hims & Hers: The Gift That Keeps On Giving
08:30am, Wednesday, 25'th Sep 2024
Hims & Hers stock is currently in the middle of a deep drawdown, with HIMS stock nearly 35% off of its recent highs. However, the telehealth platform company remains a fundamentally sound business and
Hims & Hers Is Unbelievably Cheap And Profitable: Buy Now
06:08am, Tuesday, 24'th Sep 2024
Hims & Hers is a fantastic value despite its high 'on-the-surface' P/E ratio and valuation metrics. The company's subscription-based model in healthcare, targeting chronic conditions, ensures recurrin
Hims & Hers Health, Inc. (HIMS) Rises Higher Than Market: Key Facts
06:50pm, Monday, 23'rd Sep 2024
The latest trading day saw Hims & Hers Health, Inc. (HIMS) settling at $16.44, representing a +0.86% change from its previous close.
Where to put $1,000 in stocks to make $10k in 2025
09:52am, Monday, 23'rd Sep 2024
While it is no secret that assets in the stock market can offer substantial profits to skillful investors and traders, it is sometimes difficult to discern which stocks are better than others in this
Hims & Hers offers compounded Wegovy for $99 a month to select professions
03:10pm, Wednesday, 18'th Sep 2024
U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular weight-loss drug Wegovy to patients in certain professions for $99 a month.
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform committed to breaking down barriers to safe and affordable healthcare
Hims & Hers Acquisition: How Innovation Will Flourish
05:00am, Wednesday, 18'th Sep 2024
Buying a new pharmacy will allow Hims & Hers to expand into new markets.
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
07:00am, Tuesday, 17'th Sep 2024
This telemedicine company seems to leapfrog from one hot area in healthcare to another. Its strategy of acquiring members and turning them into paid subscribers is promising.
Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note
06:51pm, Monday, 16'th Sep 2024
Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $16.28, moving -1.75% from the previous trading session.
Hims & Hers: Fear Surrounding GLP-1 Provides Another Opportunity
09:32am, Monday, 16'th Sep 2024
Hims & Hers' stock decline after GLP-1 concerns is an overreaction, presenting a strong investment opportunity. Management's consistent outperformance and strategic leadership, including key hires, bo
Hims & Hers Stock Pops After Massive Acquisition
03:05pm, Friday, 13'th Sep 2024
Hims & Hers completed the acquisition of MedisourceRX, a pharmacy that will expand in-house production. The deal included issuing stock, which will ultimately dilute shareholders.
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
10:05am, Friday, 13'th Sep 2024
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Hims & Hers Health Stock Is Crashing: Should You Buy the Dip?
08:50am, Wednesday, 11'th Sep 2024
Hims & Hers' business grew by more than 50% last quarter. The company has plenty more growth opportunities to pursue in pain management, fertility, and diabetes.
Is Hims & Hers Health the Next Teladoc?
07:50am, Wednesday, 11'th Sep 2024
Demand for telemedicine services boomed during the pandemic lockdowns. Teladoc stock price soared more than 250%, only to plunge.
Invest While You Can: Pullbacks on These 3 Stocks Won't Last Long
07:31am, Tuesday, 10'th Sep 2024
Traders are often quoted as slaves to volatility, as their entire business model is dependent on stocks moving actively to meet the conditions of a trade and spread. However, long-term value investors
